current revolution in genomics culminating in the sequencing of the human

current revolution in genomics culminating in the sequencing of the human being genome has huge potential to improve health globally. diseases.2 The sequencing of the genomes of numerous microbial pathogens and ongoing attempts to sequence the genomes of mosquito vectors (for example revealed a biochemical target present in the parasite and not in the human… Continue reading current revolution in genomics culminating in the sequencing of the human

Cetuximab in combination with an irinotecan‐containing regimen is a standard treatment

Cetuximab in combination with an irinotecan‐containing regimen is a standard treatment in patients with wild‐type (wild‐type mCRC. including an irinotecan‐based regimen but not an EGFR inhibitor. Adjuvant chemotherapy was allowed to be counted as a line of therapy if disease progression/recurrence had occurred ≤6 months after completing treatment. Patients were required to be ≥18 years… Continue reading Cetuximab in combination with an irinotecan‐containing regimen is a standard treatment